SCHEMBL8287154

SCHEMBL8287154

Cc1cc(N)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.48
GAA P10253 5/20 0.42
MAPK1 P28482 3/20 0.42
HPGD P15428 3/20 0.42
NPSR1 Q6W5P4 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
POLB P06746 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
GSK3B P49841 3/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285163 0.88 POLB (0.50) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8285238 0.87 PDE11A (0.49) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL5871846 0.87 PDE11A (0.49) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8286440 0.86 PDE11A (0.48) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8287830 0.85 PDE11A (0.48) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8287181 0.84 PDE11A (0.46) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8287832 0.84 PDE11A (0.47) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8285149 0.84 PDE11A (0.47) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL5871723 0.83 PDE11A (0.48) PDE11AGAAMAPK1HPGDNPSR1
SCHEMBL8285248 0.83 PDE11A (0.46) PDE11AGAAMAPK1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed